Related Experiment Video
Updated: May 7, 2026

13:07
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
3.7K
Prediction of coronary atherosclerosis progression using dynamic Bayesian networks
Summary
This study introduces a novel method using dynamic Bayesian networks to predict coronary atherosclerosis progression. It identifies key factors and builds a predictive model for personalized patient risk assessment.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Computational Biology
Background:
- Atherosclerosis is a progressive disease affecting coronary arteries.
- Accurate prediction of atherosclerosis progression is crucial for patient management.
- Existing models may not fully integrate diverse patient data for predictive accuracy.
Purpose of the Study:
- To develop a methodology for predicting coronary atherosclerosis progression.
- To identify key factors influencing atherosclerosis development and advancement.
- To create a patient-specific predictive model incorporating disease mechanisms.
Main Methods:
- Utilized dynamic Bayesian networks for predictive modeling.
- Integrated comprehensive patient data: demographic, clinical, biochemical, inflammatory markers, and treatment characteristics.
- Analyzed data from baseline and follow-up studies.
Main Results:
- The methodology successfully predicts atherosclerosis progression.
- Identified significant demographic, clinical, biochemical, and inflammatory factors influencing disease progression.
- Developed a predictive model offering insights into underlying disease mechanisms.
Conclusions:
- Dynamic Bayesian networks provide a robust framework for predicting coronary atherosclerosis.
- The model enhances personalized risk assessment and understanding of atherosclerosis pathogenesis.
- This approach facilitates proactive clinical decision-making in cardiovascular disease management.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Coronary Artery Disease IV: Preventive Measures
893
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
893

